Tango Therapeutics, Inc.
TNGX
$6.61
$0.111.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.57% | -5.86% | -29.15% | -14.15% | 32.61% |
| Total Depreciation and Amortization | 0.48% | 0.32% | -0.32% | -1.58% | 1.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.35% | 0.30% | 8.90% | -5.05% | 16.59% |
| Change in Net Operating Assets | 48.52% | -40.14% | 39.32% | -96.63% | 12.31% |
| Cash from Operations | 12.42% | -13.78% | -9.75% | -41.44% | 37.64% |
| Capital Expenditure | -1,123.53% | 58.87% | -7.83% | 64.06% | -64.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.22% | -41.27% | 59.66% | 151.06% | 218.27% |
| Cash from Investing | -45.16% | -41.23% | 59.84% | 156.48% | 213.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28,950.00% | -99.79% | -59.66% | 83.22% | -96.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28,950.00% | -99.79% | -59.66% | 83.22% | -96.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.64% | -167.75% | 935.52% | 116.48% | -57.90% |